Genomate helps oncologists determine the optimal targeted therapy for every cancer patient based on the individual molecular profile of their tumor. Unlike currently available solutions, Genomate can combine what we know about the unique combination of genetic alterations found in every patient to make an automated inference about the right personalized therapy.

The current system deploys 34,000+ algorithms to match the right targeted therapy to the patient's molecular diagnostic test results out of available treatment options. While recommending therapies, the algorithm considers all functional evidence, all genes and mutations detected - considering each tumor type. The algorithms behind Genomate are transparent, unbiased, and based on sound scientific principles. They are the work of more than three decades of scientific research and are backed by clinical trial data.

Instead of reporting cancer gene–treatment associations and related pieces of evidence individually, the system automatically combines all information from thousands of pieces of evidence associated with the totality of genetic alterations in an individual tumor to create a simple score in 20 milliseconds.

The output is a personalized report, which provides oncologists with a list of recommended drugs and treatment options tailored to the individual patient's molecular profile. This way, oncologists can enhance their decision-making process and deliver more effective targeted therapies to their patients.